{
  "id": 347,
  "text": "3 of that guideline (11).In December 2021, recommendations for the use of HPV mRNA tests as a primary screening test were published as part of the output of Phase 2, in WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of mRNA tests for human papillomavirus (HPV) (12).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 3 of that guideline (11).In December 2021, recommendations for the use of HPV mRNA tests as a primary screening test were published as part of the output of Phase 2, in WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of mRNA tests for human papillomavirus (HPV) (12).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据2021年12月发布的建议，世界卫生组织（WHO）在其《宫颈癌预防筛查和治疗宫颈癌前病变指南》中推荐将HPV mRNA检测作为宫颈癌初筛的一种方法。这些建议反映了在使用mRNA检测技术筛查宫颈癌中的有效性和潜力。通过检测与HPV感染相关的mRNA表达水平，可以更准确地评估患者的宫颈癌风险，从而优化筛查和治疗策略，进一步降低宫颈癌的发病率。这种方法作为初筛工具，其应用有助于提高筛查的敏感性和特异性，同时减少假阳性率。",
  "query": "宫颈癌筛查中，2021年12月有哪些关于使用HPV mRNA测试作为初筛方法的推荐？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈癌筛查中，2021年12月有哪些关于使用HPV mRNA测试作为初筛方法的推荐？\n\n<reference text>: 3 of that guideline (11).In December 2021, recommendations for the use of HPV mRNA tests as a primary screening test were published as part of the output of Phase 2, in WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: use of mRNA tests for human papillomavirus (HPV) (12).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据2021年12月发布的建议，世界卫生组织（WHO）在其《宫颈癌预防筛查和治疗宫颈癌前病变指南》中推荐将HPV mRNA检测作为宫颈癌初筛的一种方法。这些建议反映了在使用mRNA检测技术筛查宫颈癌中的有效性和潜力。通过检测与HPV感染相关的mRNA表达水平，可以更准确地评估患者的宫颈癌风险，从而优化筛查和治疗策略，进一步降低宫颈癌的发病率。这种方法作为初筛工具，其应用有助于提高筛查的敏感性和特异性，同时减少假阳性率。"
}